Home Blog Page 539

Thunderbird Resorts 2022 Half-Year / Semi-Annual Report Filed

0
Thunderbird Resorts 2022 Half-Year / Semi-Annual Report Filed
ZURICH - September 29, 2022 - (Newswire.com)

Thunderbird Resorts Inc. ("Thunderbird") (FSE: 4TR; and Euronext: TBIRD) is pleased to announce that its 2022 Half-year report has been filed with the Euronext ("Euronext Amsterdam") and the Netherlands Authority for Financial Markets ("AFM"). As a Designated Foreign Issuer with respect to Canadian securities regulations, the Half-year report is intended to comply with the rules and regulations set forth by the AFM and the Euronext Amsterdam.

Copies of the 2022 Half-year report and Unaudited Consolidated Financial Statements Report in the English language will be available at no cost at the Group's website at www.thunderbirdresorts.com. Copies in the English language are available at no cost at the Group's operational office in Panama and at the offices of our local paying agent ING Commercial Banking, Paying Agency Services, Location Code TRC 01.013, Foppingadreef 7, 1102 BD Amsterdam, the Netherlands (tel: +31 20 563 6619, fax: +31 20 563 6959, email: [email protected]). Copies are also available on SEDAR at www.SEDAR.com. 

Below are certain material excerpts from the full 2022 Half-year report the entirety of which can be found on our website at www.thunderbirdresorts.com.

Dear Shareholders and Investors:

The below summarizes the Group's performance through June 30, 2022.

A.  EBITDA: Peru property EBITDA increased by $64 thousand and adjusted EBITDA by $99 thousand over the same period in 2021. The increases were driven by a $439 thousand increase in revenue over the same period, while expenses were controlled given the inflationary environment.

B.  Profit / (Loss): Based on Continuing Operations, the Group experienced a Profit of $241 thousand, a decline of $160 thousand as compared to Half-year 2021. While cash expenses below the EBITDA line improved, the decline in income was driven by higher non-cash expenses.

C.  Net Debt: There was essentially nil progress in net debt in the period. We do expect to announce material progress with net debt by the end of the fiscal year 2022.

1.  IMPACT OF COVID-19 ON 2021 AND BEYOND

Covid-19 continues to impact on our markets. Having said that, Management has stabilized its operations and its cash management. To be prudent, however, we maintain unchanged our Management Statement on Going Concern as last updated in our 2021 Annual Report.

2.  SHAREHOLDER MANDATE AND OUR ASSETS

We continue to pursue decisions that support the best interest of shareholders according to the shareholder mandate set forth in the September 21, 2016 Special Resolutions. Please read the following carefully.

A.  Peru Real Estate Assets: As of the publication of this 2022 Half-year Report, the Group completed the process to convert a 66-suite hotel into a condominium apartment building of 66 units for sale. In the same mixed-use building, the Group also continues to own approximately 6,703 m2 of rentable-sellable office space, and 158 underground parking spaces. Please note the following:

  • The Group completed the conversion of the 66-suite hotel into condominiums. Sales are advancing. We project to have completed sale of all condominiums in the first half of 2023.
  • The Group is evaluating the conversion of its 6,703 m2 of offices to apartments. Given the pre-sale performance of the hotel conversion into condominium apartments, the Group has begun an analysis of the conversion of its office complex (located in the same building). We have contracted for construction plans and are in the budgeting mode. We have active tenants, the construction budget would likely be in excess of $3 million, and the timing of such a project could take one to two years. The Group will keep shareholders apprised.

B.  Nicaragua Gaming and Real Estate Assets: As of the publication date of this 2022 Half-year Report, the Group continues to own a 56% interest in a Nicaraguan holding company that owns the following assets: i) Gaming: Five full casinos and two slot parlors with a combined approximately 733 gaming positions; and ii) Real Estate: Approximately 4,562 m2 of land divided among 5 parcels, and some with tenant improvements as more fully detailed on page 10.

C.  Costa Rica Real Estate Asset: As of the publication of this 2022 Half Year Report, the Group continues to own a 50% interest in a Costa Rican entity that owns the 11.6-hectare real estate property known as "Tres Rios". Tres Rios, with its own, dedicated off ramp, is located close to the country's 2nd largest mall on the highway between the capital city of San Jose and the commuter city of Cartago.

GROUP OVERVIEW: The Group's consolidated profit/ (loss) summary for the six months ended June 30, 2022, as compared with the same period of 2021 is contained in the Group's 2022 Half-year Report located at www.thunderbirdresorts.com. In summary, Group revenue increased by $439 thousand or 6.7%, while adjusted EBITDA increased by $99 thousand or 4.9%.

During the half-year ended June 30, 2022, the Group engaged in the following material events:

  1. Peru Hotel Real Estate Converted to Apartment Units: As of the date of publication of this 2022 Half year Report, the Group has converted it's 66-suite hotel in Lima, Peru into a 66-unit condominium apartment complex. The Group has: i) Legally sub-divided the former hotel in to 66 individually titled apartment units; ii) Procured all change of use and other regulatory approvals; and iii) Restructured approximately $4.5 million of senior debt based on the change of use, enabling us to sell units and accelerate debt payment with each sale.
  2. The Group is evaluating the conversion of its 6,703 m2 of offices to apartments: Given the pre-sale performance of the hotel conversion into condominium apartments, the Group has begun an analysis of the conversion of its office complex (located in the same building). We have contracted for construction plans and are in the budgeting mode. We have active tenants, the construction budget would likely be in excess of $3 million, and the timing of such a project could take one to two years. The Group will keep shareholders apprised.

From the six months ended June 30, 2022 until the date of publication of this 2022 Half-year Report, the Group has engaged in the following material events:

  1. Peru Hotel Real Estate Converted to Apartment Units: The Group has now sold the majority of the units with possible completion of this transaction in the first half of 2023.
  2. Guatemala Tax Cases: In November 2019, the Third Economic court issued a resolution against the arguments of Thunderbird de Guatemala in a case related to 2009 tax period for an approximate amount of $100 thousand. An Administrative Cassation Appeal was filed in July 2021 before the Third Economic Court alleging that the judge omitted some of the arguments and facts presented by Thunderbird de Guatemala. On July 20, 2022, Thunderbird de Guatemala was served with the Supreme Court Resolution 01002-2021-00644, in which was decided to maintain the prior decisions against the Company interests. At this instance, no further challenges are available. The Company is registering a provision of approximately US$109,000 according to the amount stated in the March 19, 2021 ruling for this case.

RISK MANAGEMENT: For more detail on Risk Factors, see Chapter 5 of the Group's 2022 Half-year Report.

MANAGEMENT STATEMENT ON "GOING CONCERN": This statement is made taking into account the global health crisis and economic fallout caused by the pandemic Covid-19. There is instability in our markets and globally that could impact on Group activities in ways that are currently unpredictable. To account for the unpredictable conditions, in forecasting future cash flows in our assessment of Going Concern, Management has made certain extraordinary assumptions. Specifically, we have:

  1. Forecasted a materially negative impact on revenue for the years 2023 and 2024.
  2. Forecasted expenses to remain approximately at the levels they are as on date of publication of our 2022 Annual Report, meaning we are assuming (for Going Concern assessment only) that the Group has no more flexibility to drive down expenses further.
  3. Assumed that the Group will be able to continue to defer junior debt and to negotiate terms for repayment as liquidity becomes available.
  4. Assumed no development nor material construction, but do assume some repurposing of existing real estate to accommodate for changes in demand.
  5. Forecasted no extraordinary one-time events that may impact positively or negatively on the Group's cash flows, though such events are possible particularly given the environment.
  6. Assumed a stable regulatory environment in all countries with existing operations, and have forecasted receiving no governmental support apart from what has already been received.

Management has reviewed their plan with the Directors and has collectively formed a judgment that the Group has adequate resources to continue as a going concern for the foreseeable future, which Management and the Directors have defined as being at least the next 12 months from the filing of this 2022 Half-year Report. In arriving at this judgment, Management has prepared the cash flow projections of the Group. 

Directors have reviewed this information provided by Management and have considered the information in relation to the financing uncertainties in the current economic climate, the Group's existing commitments and the financial resources available to the Group. Specifically, Directors have considered: (i) there are probably no sources of new financing available to the Group; (ii) the Group has limited trading exposures to our local suppliers and retail customers; (iii) other risks to which the Group is exposed, the most significant of which is considered to be regulatory risk; (iv) sources of Group income, including management fees charged to and income distributed from its various operations; (v) cash generation and debt amortization levels; (vi) fundamental trends of the Group's businesses; (vii) ability to re-amortize and unsecured lenders; and (vii) level of interest of third parties in the acquisition of certain operating assets, and status of genuine progress and probability of closing within the Going Concern period. The Directors have also considered certain critical factors that might affect continuing operations, as follows:

  • Special Resolution: On September 21, 2016, the Group's shareholders approved a special resolution that, among other items, authorized the Board of Directors of the Corporate to sell "any or all remaining assets of the Corporation in such amounts and at such times as determined by the Board of Directors." This resolution facilitates the sale of any one or any combination of assets required to support maintaining of a going concern by the Group.
  • Corporate Expense and Cash Flow: Corporate expense has decreased materially in recent years, but still must accommodate for compliance as a public company.
  • Liquidity and Working Capital: As of the date of publication of this 2022 Half-year Report, the Group forecasts operating with low levels of reserves and working capital. Selling assets will be critical to creating a healthy level of working capital reserves for periods beyond the Going Concern period, which ability to liquidate assets is contingent on market factors that are not within the control of the Group.

Considering the above, Management and Directors are satisfied that the consolidated Group has adequate resources to continue as a going concern for at least the 12 months following the filing date of this report. For these reasons, Management and Directors continue to adopt the going concern basis in preparing the consolidated financial statements.

THUNDERBIRD RESORTS, INC. CONSOLIDATED STATEMENT OF FINANCIAL POSITION (Expressed in thousands of United States dollars) for the half-year ended June 30, 2022, were approved by the Board of Directors on September 29, 2022, and are contained in the Half-year Report for 2022 posted at www.thunderbirdresorts.com. The consolidated financial statements and the accompanying notes are an integral part of these consolidated financial statements. 

ABOUT THE COMPANY

We are an international provider of branded casino and hospitality services, focused on markets in Latin America. Our mission is to "create extraordinary experiences for our guests". Additional information about the Group is available at www.thunderbirdresorts.com. Contact: Peter LeSar, Chief Financial Officer ∙ Email: [email protected]

Cautionary Notice: The Half-year Report referred to in this release contains certain forward-looking statements within the meaning of the securities laws and regulations of various international, federal, and state jurisdictions. All statements, other than statements of historical fact, included in the Half-year Report, including without limitation, statements regarding potential revenue and future plans and objectives of Thunderbird are forward-looking statements that involve risk and uncertainties. There can be no assurances that such statements will prove to be accurate and actual results could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Thunderbird's forward-looking statements include competitive pressures, unfavorable changes in regulatory structures, and general risks associated with business, all of which are disclosed under the heading "Risk Factors" and elsewhere in Thunderbird's documents filed from time to time with the Euronext Amsterdam and other regulatory authorities. Included in the Half-year Report are certain "non-IFRS financial measures," which are measures of Thunderbird's historical or estimated future performance that are different from measures calculated and presented in accordance with IFRS, within the meaning of applicable Euronext Amsterdam rules, that are useful to investors. These measures include (i) Property EBITDA consists of income from operations before depreciation and amortization, write-downs, reserves and recoveries, project development costs, corporate expenses, corporate management fees, merger and integration costs, income/(losses) on interests in non-consolidated affiliates and amortization of intangible assets. Property EBITDA is a supplemental financial measure we use to evaluate our country-level operations. (ii) Adjusted EBITDA represents net earnings before interest expense, income taxes, depreciation and amortization, equity in earnings of affiliates, minority interests, development costs, and gain on refinancing and discontinued operations. Adjusted EBITDA is a supplemental financial measure we use to evaluate our overall operations. Property EBITDA and Adjusted EBITDA are supplemental financial measures used by management, as well as industry analysts, to evaluate our operations. However, Property and Adjusted EBITDA should not be construed as an alternative to income from operations (as an indicator of our operating performance) or to cash flows from operating activities (as a measure of liquidity) as determined in accordance with generally accepted accounting principles. Thunderbird's documents filed from time-to-time with the Euronext Amsterdam and other regulatory authorities.


Contact Information:
Peter LeSar
Chief Financial Officer
[email protected]
6192611138


Press Release Service by Newswire.com

Original Source: Thunderbird Resorts 2022 Half-Year / Semi-Annual Report Filed

Break the Silence; New Intensive Online Program to Help PTSD, Trauma and Anxiety

0
Break the Silence; New Intensive Online Program to Help PTSD, Trauma and Anxiety
5 Week Intensive Online Program to Help With Relief From PTSD, Anxiety and Stress for Those Who've Experienced Trauma


Purple Heart Behavioral Health logo

This is the logo for Purple Heart Behavioral Health

SCOTTSDALE, Ariz. - September 29, 2022 - (Newswire.com)

Purple Heart Behavioral Health LLC, a premier telepsychology trauma service, announced today an innovative program for PTSD, Anxiety and Stress treatment. The program is a 5-week intensive online program that includes various treatments that have scientific empirical evidence to be effective in treating PTSD, anxiety and stress. 

This innovative new online program offers treatments that have been scientifically shown to be effective in helping people overcome these difficulties. Clinically proven treatments delivered conveniently through telepsychology services bridges rural/urban gaps where resources are sparsely available making quality care accessible to those who need it most regardless of geographical limitations. A compassionate response addressing needs unmet until now.

These therapies include Eye Movement Desensitization Processing (EMDR), Dialectical Behavioral Therapy (DBT), and Cognitive Behavioral Therapy (CBT). Program participants are treated in both individual and group sessions via HIPAA compliant video. Additional psychoeducational videos augment treatment to ensure participants have an opportunity to deeply learn skills and methods taught and used during the program. 

Participants may receive treatment in 31 US states from the comfort of their home, office or hotel with a laptop or tablet. Meeting online prevents obstacles such as driving in traffic, home responsibilities, and confidentiality. Research indicates similar efficacy for face to face and video therapy. 

To date, the Founder of Purple Heart Behavioral Health LLC has guided 100s of people to include military members, Veterans, and civilians through their healing journey. This program will allow more people to gain healing quicker than traditional therapy. Each week builds upon the next with participants attaining new skills, releasing maladaptive behaviors, and gaining functioning all while processing traumatic events that may have caused the symptoms. 

"It is with great happiness and genuine excitement that we announce the launch of Purple Heart's online intensive program," said Dr. Angela Kenzslowe, Psychologist and founder of Purple Heart Behavioral Health LLC.  "Our mission is to help people get back in the fight of life faster. This is innovative, on cutting edge, and definitely needed." 

Says Dr. Kenzslowe: "PTSD and anxiety has become such a crisis in our country, we need to have ways to reach the most people in the quickest way possible. This online program is part of the solution." 

About:

Purple Heart Behavioral Health LLC was founded by Dr. Angela Kenzslowe in 2016. She is an Army Veteran and was later trained by the Department of Defense to treat trauma, anxiety, stress, and other mental health challenges. The company's focus is to provide ethical, evidence-based treatment to those who suffer from PTSD, anxiety and stress while enabling patients to be in their most comfortable space such as home or office. 

For more information about Purple Heart Behavioral Health LLC, please visit www.purpleheartbh.com


Contact Information:
Tynan Hilliard
Chief Operating Officer, Purple Heart Behavioral Health LLC
[email protected]
602-529-8120

Angela Kenzslowe
CEO, Purple Heart Behavioral Health LLC
[email protected]
602-529-8120


Press Release Service by Newswire.com

Original Source: Break the Silence; New Intensive Online Program to Help PTSD, Trauma and Anxiety

Ziemer Announces GALILEI ColorZ With ZEISS VERACITY Surgical Compatibility

0
Ziemer Announces GALILEI ColorZ With ZEISS VERACITY Surgical Compatibility
ALTON, Ill. - September 29, 2022 - (Newswire.com)

Ziemer USA, Inc., a wholly owned subsidiary of Ziemer Group AG (Port, Switzerland), a developer and manufacturer of the Femtosecond Laser Technology (FEMTO LDV Z8) and Corneal Diagnostic equipment (GALILEI ColorZ), announces the introduction of GALILEI ColorZ with ZEISS VERACITY Surgical compatibility.

"We continue to invest in new technologies making it easier for our customers and surgeons to deliver great patient outcomes every day. We are excited about the upgrades we have made with the GALILEI ColorZ and the connectivity offered with ZEISS VERACITY Surgical", says David Bragg, President of Ziemer USA & Canada.

The GALILEI ColorZ G4 and G6 represent the new generation of the renowned diagnostic platform, offering multilayer TopView images in vibrant colors and high contrast to provide enhanced visualization of numerous details including blood vessels, iris patterns and the pupil. Now, with access to ZEISS VERACITY Surgical, the GALILEI ColorZ G6 is the all-in-one device that takes refractive cataract surgery planning to the next level.

ABOUT ZIEMER USA, INC.

Ziemer believes in constantly innovating and improving technology to better serve our doctors. Our Swiss-engineered femtosecond lasers are uniquely designed to perform multiple procedures and give patients a safe and seamless experience. Our GALILEI ColorZ diagnostic devices are now ZEISS VERACITY Surgical compatible and will give you precise measurements to enhance your treatment planning.

For more information, please visit our website at www.ziemerusa.com or contact us directly at [email protected].


Contact Information:
Brad Hurt
Vice President of Business Development & Marketing
[email protected]
866-708-4490


Press Release Service by Newswire.com

Original Source: Ziemer Announces GALILEI ColorZ With ZEISS VERACITY Surgical Compatibility

Northwell Holdings Announces $3 Million Strategic Investment in Expressive Communication Startup Hume AI to Empower a New Wave of Empathic Healthcare Applications

0
Northwell Holdings Announces  Million Strategic Investment in Expressive Communication Startup Hume AI to Empower a New Wave of Empathic Healthcare Applications
Hume AI's platform equips researchers and developers with machine learning tools to better understand vocal and nonverbal communication, improving clinical research, clinical practice, and patient outcomes.

NEW YORK - September 29, 2022 - (Newswire.com)

Northwell Holdings, the for-profit investment arm of Northwell Health, New York State's largest healthcare provider and private employer, today announced a strategic investment of $3 million in Hume AI, a leading expressive communication research lab and technology company. The investment aims to address the growing demand for scientific tools to understand language and nonverbal expression in the healthcare industry. Hume AI plans to use the funding to refine their advanced machine learning models for use in health applications, including clinical research, patient screening, and accessibility technology.

These models, accessible through Hume AI's integrated platform, address a significant shortcoming of natural language understanding (NLU) tools, which convert speech into text. NLU tools overlook how the meaning of speech can be transformed dramatically by its tune, rhythm, and timbre, along with nonverbal utterances such as laughs, sighs, and gasps. Such features are particularly important for understanding health conditions such as pain, major depression, and cognitive impairment. With NLU rapidly being integrated into healthcare applications, Hume AI's platform will enable a more accurate understanding of expressive communication at every step of the patient's journey, from screening to diagnosis and treatment.

"Technologies that draw upon the latest scientific research to help us better understand not just what people say, but how they say it, have profound potential to benefit patients," said Rich Mulry, CEO and President of Northwell Holdings. "We already see rising demand for this technology in treatment, clinical research, telehealth applications and more. To promote the careful development of these potentially transformative technologies, we are excited to launch our partnership with Hume AI through an investment that reflects our confidence in Dr. Alan Cowen and his groundbreaking team."

Hume AI builds its models using new peer-reviewed scientific research and algorithms designed to minimize bias. Previous technologies for understanding nonverbal expression have focused on the expression of six emotions—happiness, sadness, anger, disgust, fear, and surprise—based on established psychological models. Scientific research published in leading journals by Hume AI's founder and CEO Dr. Alan Cowen, Chief Scientific Advisor Dr. Dacher Keltner, and colleagues has given rise to a more nuanced theory of human expressive behavior. Known as semantic space theory, this work documents how expressions involve complex patterns in language, speech prosody, nonverbal vocalizations like sighs and chuckles, and movement in more than 30 facial muscles. To translate this research into effective machine learning models, Cowen and his team have collected new experimental data from around the world that allow them to characterize the nuances of expressive communication within and across cultures with less bias and more precision.

"In recent years, there have been major scientific advances in our understanding of expressive communication," Cowen said. "For the first time, we can equip researchers and practitioners in the healthcare space with objective, nuanced, and multidimensional measures of human expression. We are deeply grateful to Northwell Holdings for recognizing the extraordinary potential of this new technology to improve people's lives and address health inequities. Our partnership will support translational researchers studying how expressive signals relate to mood, mental health, and pain in neuropsychiatric disorders, as well as customers developing new interventions to restore emotional intonation to speech aids, annotate emotional context, and guide empathic behavior."

For more information on Hume AI, click here.

About Hume AI 

Hume AI is a leading expressive communication research lab and startup with a mission of aligning technology with human well-being. Based on scientific research that reveals a broader spectrum of expressive behavior than previously known, Hume AI offers the world's most accurate and comprehensive tools for understanding nonverbal expression, including speech prosody, vocalizations like sighs, and facial expressions. Led by founder and CEO Dr. Alan Cowen, an established expert in the field of affective science, Hume AI develops its models using new scientific research that it conducts and regularly publishes in leading journals. The company provides its datasets and models through a unified API platform. Learn more about Hume AI at www.hume.ai and follow us on LinkedIn and Twitter.

About Northwell Holdings

Northwell Holdings ("Holdings"), a fully owned, for-profit subsidiary of Northwell Health, creates value for the health system by investing in early-stage companies, establishing commercial joint ventures, cultivating internally-developed ideas and bringing them to market, and advancing data partnerships that drive innovation in patient care, health diagnostics, and deep technology. We invest in companies that are aligned with Northwell's mission, promote better health outcomes, improve patient experience, and increase efficiencies in care delivery and services. Through strategic partnerships, Holdings leverages the health system's robust enterprise data assets to develop AI-enabled solutions that address healthcare inequities. We combine Northwell Health's clinical and healthcare business expertise and entrepreneurial spirit to bring concepts to life. Northwell Health is New York's largest healthcare system. To learn more, visit us here and follow us on LinkedIn.


Contact Information:
General Inquires
[email protected]


Press Release Service by Newswire.com

Original Source: Northwell Holdings Announces $3 Million Strategic Investment in Expressive Communication Startup Hume AI to Empower a New Wave of Empathic Healthcare Applications

AMAX Launches LiquidMax™ LA-2 Liquid Cooled Data Science Workstation

0
AMAX Launches LiquidMax™ LA-2 Liquid Cooled Data Science Workstation
Supporting up to 7 GPUs for Higher Density Workloads

FREMONT, Calif. - September 29, 2022 - (Newswire.com)

AMAX, a leading provider of customized rack-scale High-Performance Computing (HPC) solutions and server appliance manufacturing, announces the new LiquidMax™ LA-2 workstation supporting the AMD 3rd Gen EPYC™ 7003 CPU series with AMD 3D V-Cache™ technology and up to 64 cores to its LiquidMax™ series of liquid-cooled workstations. The LA-2 boasts the capability to support up to seven NVIDIA A100 or A6000 GPUs for increased HPC power to complete high-density workloads faster. It is an intelligent GPU workstation for enterprise and research infrastructures that need to accelerate deep learning training and scientific visualization applications. With the introduction of the LA-2 by AMAX, researchers can work with large datasets at interactive speeds without dependency on expensive cloud platforms or competing resource allocation from on-premise clusters.

The ultra-quiet LiquidMax™ LA-2 provides the most powerful and eco-friendly platform in convenient workstation form, backed by a full warranty with global tech support for peace of mind. The single CPU LA-2 features a single root topology to maximize GPU to GPU bandwidth, up to 4TB of DDR4 system memory, and up to 176TB of raw storage across 8 hot-swappable WD Gold® Enterprise Class Hard Drives for maximum storage capacity. The user-friendly turnkey design showcases AMAX's engineering expertise with a proprietary enterprise-grade liquid cooling system featuring custom patented CPU and GPU cold plates for more efficient thermal management and dual Gold® rated power supplies. The chassis includes durable casters for mobility and real-time LED display monitoring of key safety functions.

The expansion of the LiquidMax™ series by AMAX with the LA-2 data science workstation provides unrivaled flexibility of configuration and performance options to meet growing HPC demands at any scale. For more information on the LA-2 and to view the full spectrum of advanced liquid-cooled solutions by AMAX, visit us here. 

About AMAX
AMAX is an award-winning global leader in data center, open-architecture platforms, HPC, deep learning, application-tailored cloud, and OEM server manufacturing solutions designed toward the highest efficiency and optimal performance. Whether you are a Fortune 100 company seeking significant cost savings through better efficiency for your global data centers or a software startup seeking an experienced manufacturing partner to design and launch your flagship product, AMAX is your trusted solutions provider, delivering the results you need to meet your specific metrics for success. For more information about AMAX and our commitment to the highest standards of quality, design, and support, learn more about us here.


Contact Information:
Vily Vu
Marketing Manager
[email protected]
800.800.6328


Press Release Service by Newswire.com

Original Source: AMAX Launches LiquidMax™ LA-2 Liquid Cooled Data Science Workstation

Atlanta Urgent Care Provides COVID-19 Booster Information for Patients

0
Atlanta Urgent Care Provides COVID-19 Booster Information for Patients
The noted Atlanta, Georgia urgent care, along with providing the new COVID-19 vaccine, offers need-to-know knowledge about the booster that targets Omicron subvariants, BA.4 and BA.5.


Emergency Medicine & Family Nurse Practitioner Ariel Esteves, located in Atlanta, GA

Emergency Medicine & Family Nurse Practitioner located in Atlanta, GA

ATLANTA - September 29, 2022 - (Newswire.com)

As the new bivalent COVID-19 booster makes its way to the public, Atlanta, Georgia urgent care WestsideMed answers burning questions about the new shot.

On September 1st, 2022, CDC director Rochelle P. Walensky, M.D., M.P.H., endorsed using the new COVID-19 booster. 

The experts at WestsideMed, led by its founder, emergency medicine & family nurse practitioner Ariel Esteves, shine a light on the basics of the bivalent booster and how it helps people combat the dominant Omicron variant.

The Omicron Variant In Georgia

In November 2021, the World Health Organization (WHO) labeled what we now know as the Omicron variant as a Variant of Concern. The ease of transmissibility was unlike previous forms of COVID-19, leading to a monumental surge in the United States.

In WestsideMed's home state of Georgia, the Omicron variant was especially transmissible.

"In fact, in Georgia, health systems experienced a staggering 100% to 200% hospitalizations in a weeklong period in late December 2021. And we experienced much of the same with the newer Omicron subvariants," says Esteves.

After the initial wave of the Omicron surge in 2021 and early 2022, two subvariants, BA.4 and BA.5, appeared in late spring and early summer.

"And Omicron's transmissibility and virulence increased with the spread of the dominant BA.4 and BA.5 subvariants," Esteves continues. "With them, the ease of transmissions via spike protein mutations has increased significantly."

Ariel Esteves assures Atlantans that this booster promises to bolster immune responses to the new subvariants.

"While these subvariants are more resistant to antibodies of the original virus, your body  willrecognize BA.4 and BA.5," says Esteves. "In short, being vaccinated will still give you protection against severe illness and death."

The Atlanta urgent care ensures that COVID-19 vaccines are available to all adults who need them. 

And the Atlanta urgent care stresses testing oneself for COVID-19, as the symptoms are similar to other medical conditions like strep throat and mono, which causes extreme fatigue.

Checking Medical Boxes With WestsideMed

Along with dispensing medical advice on its blog, WestsideMed provides quick, safe, and effective medical care in its Atlanta location on Marietta Boulevard.

With its team of talented medical providers, led by emergency medicine & family nurse practitioner Ariel Esteves, the Atlanta urgent care ensures that patients needing a quick medical fix are within their grasp.

Whether it's a quick checkup to ensure optimal health, treating sports injuries, or giving EKG readings in Atlanta, the urgent care promises to provide a safe environment for everyone.

The new round of COVID-19 bivalent boosters is just one more way to effortlessly take care of one's health at this Atlanta urgent care.


Contact Information:
Ariel Esteves
Emergency Medicine & Family Nurse Practitioner
[email protected]
217-269-8205


Press Release Service by Newswire.com

Original Source: Atlanta Urgent Care Provides COVID-19 Booster Information for Patients

Roadpass Empowers Its Users in Time for Winter With New Roadpass University Courses Focused on RV Ownership and Maintenance

0
Roadpass Empowers Its Users in Time for Winter With New Roadpass University Courses Focused on RV Ownership and Maintenance
The brand is helping its users learn the ropes from experts with free online courses tailored for RV shoppers, owners, and enthusiasts.

CHICAGO - September 29, 2022 - (Newswire.com)

Roadpass Digital, the company empowering roadtrippers, campers, and RVers to hit the open road, has added new Roadpass University courses to help RVers this autumn and winter. Roadpass University houses a library of online courses led by RV experts across a variety of topics relevant to RV ownership, from brand-new RVers to seasoned, full-time road warriors. 

The new courses that are now available in Roadpass University include:

  1. Introduction to RV Ownership: This course guides a user through the first year of owning an RV, offering tips on everything from picking up a new RV from the dealer to winterizing and long-term storage. 
  2. RV Maintenance Made Easy: This course offers troubleshooting and maintenance tips for some of the most important systems and appliances in your RV. With these preventative maintenance tips, RVers can stay ahead of regular wear and tear before it becomes a bigger problem. 

"As the temperature cools, we're here to ensure our community of RVers are well-prepared and know the ins and outs of their RV," said Stephanie Puglisi, Vice President of Content at Roadpass Digital. "Roadpass University's library of courses is the best way to quickly gain the knowledge you need, so you can make the most of your RV."

Enrollment in Roadpass University is free. Courses are offered in two formats depending on the complexity of the subject matter: shorter bootcamps and longer in-depth courses. Courses include videos, PDFs, downloadable checklists, and quizzes. Other topics range from RV shopping, an introduction to campgrounds and boondocking, campground etiquette, RV organization tips, and an introduction to RV power, including solar 101. New courses are being added regularly to the Roadpass University website. Future topics will include trip planning, renting an RV, and more. 

Roadpass Digital offers a portfolio of leading digital apps that provide campers, RVers, and roadtrippers with end-to-end trip discovery and planning tools. Roadpass Digital's brands include Roadtrippers, Campendium, Togo RV, and RVillage. 

To learn more about Roadpass Digital, visit https://roadpass.com/ or contact [email protected]. 
 

About Roadpass Digital 

Roadpass Digital is focused on empowering roadtrippers, campers, and RVers to hit the open road. With 6,000,000+ people using apps powered by Roadpass, the company is the leading platform for road travel and outdoor experiences. Roadpass Digital has offices in Chicago, Cincinnati, and Auckland. Learn more about Roadpass Digital and Roadtrippers, Campendium, Togo RV, and RVillage products at roadpass.com.


Contact Information:
Lauren Lillis
Director, Marketing & Communi
[email protected]
Related Files
Roadpass Digital Logo Color.png



Press Release Service by Newswire.com

Original Source: Roadpass Empowers Its Users in Time for Winter With New Roadpass University Courses Focused on RV Ownership and Maintenance

World Renowned Medical Pioneer, Inventor, Mentor, 94 Year-Old Orthopaedic Surgeon William H. Harris, MD, Receives Lifetime Achievement Award

0
World Renowned Medical Pioneer, Inventor, Mentor, 94 Year-Old Orthopaedic Surgeon William H. Harris, MD, Receives Lifetime Achievement Award
William H. Harris, MD, Honored for His Six-Decade-Long Career in Orthopaedics and Transformative Contributions in the Field of Hip Replacements

EVERETT, Mass. - September 29, 2022 - (Newswire.com)

Orthopaedic Summit Evolving Techniques (OSET), the non-profit organization dedicated to educational advancement in orthopaedics, with Orthopaedic Surgeon Wayne G. Paprosky, MD (pictured at far left) from Rush Presbyterian-St. Luke's Medical Center, presented the Lifetime Achievement Award to 94-year-old William H. Harris, MD, (pictured at far right) Founder and Director Emeritus of the Massachusetts General Hospital, Harris Orthopaedics Laboratory. (Pictured second from left) is Orthopaedic Surgeon Kevin D. Plancher, MD, MPH, Founder of OSET and Ivan Tornos, President & COO of Zimmer Biomet (pictured third from left).

Dr. Harris will forever be known for his invention of the Harris Hip Score (HHS), used for evaluating patient-reported outcomes in hip arthroplasty and later his important discovery into effective prevention of Deep Vein Thrombosis (DVT) after hip surgery, which has saved many lives. His laboratory helped unravel a totally new, destructive disease damaging total hip and total knee reconstruction. They then innovated a new material, which improved the new prosthetic bearing surface, eliminating that bone destruction and greatly extending the life of total joint implants. His Harris Harvard Hip Course was the seminal course that set the bar for education in total joints for years to come.

###

ABOUT ORTHOPAEDIC SUMMIT EVOLVING TECHNIQUES 

Orthopaedic Summit Evolving Techniques (OSET) is a 501c3 organization founded by Orthopaedic Surgeon, Kevin D. Plancher, MD, MPH, FAOA, FAAOS, FACS, and Conference Chair, Brian D Busconi, MD of UMASS Medical Center in 2010. OSET is accredited by the ACCME for Continuing Medical Education (CME) Credits and Accredited by the American Physical Therapy Association MA (APTA) for Continuing Education Units (CEU) for Healthcare Professionals. OSET is committed to advancing the education of healthcare professionals by providing an educational platform that includes hands-on training, live surgeries, and didactic presentations in the musculoskeletal field, including all orthopaedic, sports medicine and sports rehab specialties. www.orthosummit.com


Contact Information:
Fred Yaeger
President
[email protected]
914 525 9198


Press Release Service by Newswire.com

Original Source: World Renowned Medical Pioneer, Inventor, Mentor, 94 Year-Old Orthopaedic Surgeon William H. Harris, MD, Receives Lifetime Achievement Award

UM6P Ventures Invests in Infiuss Health to Improve Clinical Trial Participation and Health Equity in Africa

0
UM6P Ventures Invests in Infiuss Health to Improve Clinical Trial Participation and Health Equity in Africa
Democratizes access to clinical research in Africa by diversifying participant cohorts and shortening drug development timelines

CASABLANCA, Morocco - September 29, 2022 - (Newswire.com)

Today, UM6P Ventures announced its investment in Infiuss Health. The startup is developing a decentralized SaaS platform to power remote research and clinical trials in Africa. 

Pharmacological companies attempt to include a large and varied population within their phased trial cohorts to prove their medical thesis. However, Africans, a significant group of genetically diverse participants, are not traditionally well represented within their demographic profile, rendering their trial outcomes potentially skewed.

There is a need for researchers to select a wider range of people from different demographics to participate in clinical research to reduce bias, promote health equity, and produce innovative scientific findings.

To date, Africa's participation is only a small percentage of the global clinical trials landscape, as a result of the regulatory and ethical implications of clinical trials. To that end, several individual regulatory bodies have joined efforts to ensure that clinical trials in African countries are conducted in accordance with international best clinical practices and ethical standards. Thus, with new regulatory structures in place in Africa, medicinal effectiveness and availability will be improved. In fact, Infiuss Health only services sponsors that have previously been approved by the U.S. FDA, which ensures that trials comply with the exacting framework required by U.S. regulations. 

Infiuss Health provides clinical trial access to African participants and allows pharmaceutical companies to conduct and monitor these trials via the Infiuss Health Probe Platform. Through their direct-to-participant approach, they help corporate and academic researchers diversify their cohorts by connecting them directly to thousands of eligible African participants to take part in their clinical studies. 

"Our main mission is to make clinical research accessible to all Africans. We're very pleased to have UM6P Ventures' support as Infiuss Health continues to grow African clinical trials that will have enormous benefits, including improved healthcare and patient outcomes.", stated Melissa Bime, CEO and Founder of Infiuss Health. 

Through a single dashboard, the all-in-one software platform helps companies identify and select the right sites for trials, manage the entire research process, remotely recruit participants, collect remote consent, gather, and analyze data and provide virtual support faster and cheaper than third-party contract research organizations. 

"The clinical trial phase is decisive in the pharmacological development lifecycle. This is a branch of our Healthtech investment thesis that we have been actively investigating. The Infiuss Health team brings a solution, expertise, and experience that adds critical elements to our health science and technology ecosystem. We are confident in their ability to deliver on their value proposition and contribute to the improvement of the health system in Africa," said Yasser Biaz, CEO of UM6P Ventures. 

Public Relations Contacts

Infiuss Health 

Bekah Myers

+1 9389003666 

[email protected], https://infiuss.com/ 


Contact Information:
Kaoutar Sellami
Project Manager
[email protected]
212662377896


Press Release Service by Newswire.com

Original Source: UM6P Ventures Invests in Infiuss Health to Improve Clinical Trial Participation and Health Equity in Africa

Theory Wellness Announces Expansion Into Vermont Recreational Cannabis Market With Brattleboro Location

0
Theory Wellness Announces Expansion Into Vermont Recreational Cannabis Market With Brattleboro Location
A leader in East Coast cannabis, Theory Wellness announced plans to open in their third state to bring their world-class retail operations to the blossoming Vermont cannabis industry.

STONEHAM, Mass. - September 29, 2022 - (Newswire.com)

Theory Wellness ("Theory" or "the Company") has announced plans to enter the Vermont recreational cannabis market with a retail location in Brattleboro. The announcement comes on the eve of recreational cannabis sales, expected to begin as early as October 1. Vermont will soon become the third East Coast state to offer recreational cannabis sales.

Theory is no stranger to emerging recreational cannabis markets, being one of the first in Massachusetts and opening on day one of adult-use cannabis sales in Maine. However, unlike in the other states, they intend to focus on retail, a pivot from their vertically integrated models in surrounding markets. 

"Vermont is one of the most interesting regulatory models on the East Coast for cannabis. The emphasis on streamlined licensing for craft farmers will allow for a terrific mix of top-quality products in our dispensary. By focusing on retail, we look forward to showcasing to our customers this unique network of local cultivators, many of which have been producing high-quality flower for years," shares Brandon Pollock, CEO of Theory Wellness.

As of today, the Vermont Cannabis Control Board has approved over 200 licenses for cultivation sites across the State. Theory looks forward to serving customers with its location at 768 Putney Road, currently under construction. The location will add new jobs to the town in addition to contributions relating to the 14% in excise taxes on sales.

While there is no official opening date for their Brattleboro dispensary, the Company expects to be operational this fall. Their progress and status of the retail location can be found on their website. 

About Theory Wellness

Theory Wellness is an independently owned and operated cannabis company that cultivates and manufactures cannabis, and serves patients and consumers in Massachusetts, Maine, and soon-to-be Vermont. Theory sources unique genetics and creates premium products that include flower, concentrates, edibles and infusions, and brands. For more information, visit https://theorywellness.org/.


Contact Information:
Thomas Winstanley
Chief Marketing Officer
[email protected]
4138229054


Press Release Service by Newswire.com

Original Source: Theory Wellness Announces Expansion Into Vermont Recreational Cannabis Market With Brattleboro Location